Skip to main content
Clinical Trials/NCT06558474
NCT06558474
Recruiting
Not Applicable

Optimization of Percutaneous Coronary Intervention After Stent Implantation With Liberal Use of High-pressure Non-compliant Balloon Post-dilatation Versus Contemporary Practice

Cathreine BV1 site in 1 country12,000 target enrollmentSeptember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Cathreine BV
Enrollment
12000
Locations
1
Primary Endpoint
Occurrence of target vessel revascularization, myocardial infarction and all-cause mortality
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

To achieve optimal long-term clinical results after percutaneous coronary intervention (PCI), adequate deployment of stents is essential. Thorough expansion of the stent and full apposition of stent struts against the vessel wall are determining factors for preventing stent thrombosis and restenosis for bare-metal as well as drug-eluting stents (DES). Standard coronary angiography is limited in assessing accurate vessel size and characterizing tissues and calcium load. Therefore, stent underexpansion frequently occurs after stent deployment.

Post-dilation is often performed to achieve optimal stent expansion and reduce stent malapposition of stent struts, aiming to reduce stent thrombosis and restenosis both short term as long term. However, there are limited studies that have explored the effect of post-dilatation for stent optimization on clinical outcomes. As a result of the restricted evidence, there is no consensus whether post-dilatation should be used routinely in clinical practice and the extent to which post-dilatation is being utilized remains unclear.

For this reason, the OPTIMIZE PCI was designed, a national registry-based quality improvement project to implement a liberal post-dilatation strategy in multiple PCI centers in the Netherlands. As part of the OPTIMIZE-PCI, a retrospective observational analysis will eventually be conducted to evaluate whether adopting this strategy has led to improved clinical outcomes after PCI in terms of major adverse cardiac events.

Detailed Description

The Netherlands Heart Registration (NHR) is an independent organization in which Dutch hospitals prospectively register standard sets of baseline, procedural and outcome data for all invasive cardiac procedures, including PCI. Data provided to the NHR are extensively checked on completeness and quality, reviewed with audit reports by independent trained research nurses and discussed by cardiologists in registration committees. Multiple audits are conducted annually by the NHR for data validation and verification. A waiver for informed consent for analysis with the data of the NHR data registry is obtained.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
May 1, 2026
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cathreine BV
Responsible Party
Principal Investigator
Principal Investigator

Koen Teeuwen

Principal investigator

Cathreine BV

Eligibility Criteria

Inclusion Criteria

  • All patients \>18 years old who undergo PCI for any indication are included in the register of the Netherlands Heart Registration and therefore included in the final analysis of this project

Exclusion Criteria

  • If a patient has multiple PCIs within 365 days, only the first procedure is included.

Outcomes

Primary Outcomes

Occurrence of target vessel revascularization, myocardial infarction and all-cause mortality

Time Frame: 30 day

The primary composite end point of major adverse cardiac events is the occurrence of target vessel revascularization, myocardial infarction and all-cause mortality.

Secondary Outcomes

  • All cause mortality(30 days, 1 year)
  • Target vessel revascularization(30 days and 1 year)
  • Myocardial infarction(30 day)

Study Sites (1)

Loading locations...

Similar Trials